Relative survival in elderly cancer patients in Europe

European Journal of Cancer

Volumn 34, Issue 14, 1998, Pages 2264-2270

  Vercelli, M ^a,b   Quaglia, A ^a   Casella, C ^b   Parodi, S ^b   Capocaccia, R ^c   Martinez Garcia, C ^d  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

Author keywords

Cancer; Elderly patients; Europe; Relative survival rates

Indexed keywords

AGED; ARTICLE; CANCER SURVIVAL; COMORBIDITY; ELDERLY CARE; EUROPE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; SURVIVAL TIME;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; EUROPE; FEMALE; HUMANS; MALE; NEOPLASMS; PROGNOSIS; RESIDENCE CHARACTERISTICS; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 0032413790     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00325-6     Document Type: Article

References (30)

1. EU population in 2050. Girls could live to 87 & boys to 83. Total population back to 1950 level? (Eurostat Statistics in focus, population and social conditions, no 7/97. Beyond the predictable: demographic changes in the EU up to 2050). PRESSOFFICE@EUROSTAT, CEC, BE. No 4597, 24 June 1997.
2. Monfardini S., Yancik R. Cancer in the elderly: meeting the challenge of an aging population. J Natl Cancer Inst. 85:1993;532-538.
3. Yancik R. Cancer burden in the aged. An epidemiologic and demographic overview. Cancer. 80:1997;1273-1283.
4. Ferlay J, Black RJ, Pisani P, Valdivieso MT, Parkin DM. EUCAN90: Cancer in the European Union. IARC CancerBase No.1, IARC Press, Lyon 1996.
5. Havlik R.J., Yancik R., Long S., Ries L., Edwards B. The National Institute on aging and The National Cancer Institute SEER collaborative study on comorbidity and early diagnosis of cancer in the elderly. Cancer. 74:1994;2101-2106.
6. Fentiman IS, Tirelli E., Monfardini S, et al. Cancer in the elderly: why so badly treated? Lancet 1990, 335, 1020-1022.
7. Berrino F, Estève J, Coleman MP. Basic issues in estimating and comparing the survival of cancer patients. In Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Estéve J, eds. Survival of Cancer Patients in Europe. The EUROCARE Study. IARC Scientific Publication No. 132. Lyon, International Agency for Research on Cancer, 1995, 447-463.
8. Hakulinen T., Abeywickrama K.H. A computer program package for relative survival analysis. Computer Prog Biomed. 19:1985;197-207.
9. DeAngelis R., Capocaccia R., Verdecchia A. Estimating relative survival of Italian cancer patients from data of sparse cancer registries. Tumori. 83:1997;33-38.
10. Micheli A., Gatta G., Verdecchia A. Studying survival of cancer patients in different populations: its potential and role. Tumori. 83:1997;3-8.
11. Kant A.K., Glover C., Horm J., Schatzkin A., Harris B.T. Does cancer survival differ for older patients? Cancer. 70:1992;2734-2740.
12. Vercelli M., Quaglia A., Casella C., Mangone L. The ITACARE Working Group. Cancer patient survival in the elderly in Italy. Tumori. 83:1997;490-496.
13. Cohen H.J. Biology of aging as related to cancer. Cancer. 74:1994;2092-2100.
14. McKenna R.J. Clinical aspects of cancer in the elderly: treatment decisions, treatment choices, and follow-up. Cancer. 74:(7 suppl.):1994;2107-2117.
15. Busch E., Kemeny M., Fremgen A., Osteen R.T., Winchester D. P., Clive R.E. Patterns of breast cancer care in the elderly. Cancer. 78:1996;101-111.
16. Kane R.A. Psychosocial issues - psychological and social issues for older people with cancer. Cancer. 68:1991;2514-2518.
17. Goodwin J.S., Samet J.M., Hunt W.C. Determinants of survival in older cancer patients. J Natl Cancer Inst. 88:1996;1031-1038.
18. Coebergh JWW. Summary and discussion of results. In Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Estève J, eds. Survival of Cancer Patients in Europe. The EUROCARE Study. IARC Scientific Publication No. 132. Lyon, International Agency for Research on Cancer, 1995, 447-463.
19. Ciatto S., Cecchini S., Isu A., Maggi A., Cammelli S. Determinants of non-attendance to mammographic screening. Analysis of a population sample of the screening program in the district of Florence. Tumori. 78:1992;22-25.
20. Costanza M.E. The extent of breast cancer screening in older women. Cancer. 74:1994;2046-2050.
21. Yancik R., Ries L.A.G., Yates J.W. Breast cancer in aging women. A population-based study of contrasts in stage, surgery and survival. Cancer. 63:1989;976-981.
22. Pike M.C., Krailo M.D., Henderson B.E., Casagrande J.T., Hoel D.G. "Hormonal" risk factors, "breast tissue age" and age-incidence of breast cancer. Nature. 303:1983;767-770.
23. Yancik R. Ovarian cancer - age contrasts in incidence, histology, disease stage at diagnosis, and mortality. Cancer. 71:1993;517-523.
24. Mandelblatt J., Gopaul I., Wistreich M. Gynecological cancer of elderly women: another look at Papanicolau smear testing. JAMA. 256:1986;367-371.
25. Teeter S.M., Holmes F.F., McFarlane J. Lung carcinoma in the elderly population. Influence of histology on the inverse relationship of stage to age. Cancer. 60:1987;1331-1336.
26. Mizushima Y., Kashii T., Yoshida Y., Sugiyama S., Kobayashi M. Characteristics of lung cancer in the elderly. Anticancer Res. 16:1996;3181-3184.
27. Heimdal K., Fossa S.D. Urologic cancer in elderly patients. Curr Opin Oncol. 5:1993;568-573.
28. Kiemeney LALM, Coebergh JWW, Koper NP, et al. Bladder cancer incidence and survival in the south-eastern part of the Netherlands, 1975-1989. Eur J Cancer 1994, 30, 1134-1137.
29. Trimble E.L., Carter C.L., Cain D., Freidlin D.B., Ungerleider R.S., Friedman M.A. Representation of older patients in cancer treatment trials. Cancer. 74:(7 suppl.):1994;2208-2214.
30. Tirelli U, Zagonel V, Errante D, et al. A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphomas. J Clin Oncol 1992, 10, 228-236.